INS and metabolic syndrome: Le Chatelier et al. first demonstrated that individuals with low gene richness in the microbiome are characterized by adiposity, insulin resistance, and dyslipidemia, and that gene counts correlate with metabolic parameters, like insulin levels and insulin resistance [51].